medigraphic.com
ISSN 1029-3043 (Electronic)

2012, Number 4

<< Back Next >>

Medicentro 2012; 16 (4)

Characterization of cardiovascular risk and of metabolic syndrome risk in pregnant women at risk of preeclampsia-eclampsia

Suárez GJA, Gutiérrez MM

Language: Spanish
References: 17
Page: 218-223
PDF size: 152.92 Kb.


ABSTRACT

Introduction: Risk factors for preeclampsia-eclampsia include cardiovascular and metabolic syndrome risks. Objectives: To identify the cardiovascular and metabolic syndrome risk factors in a population of pregnant women at risk of preeclampsia-eclampsia. Method: A descriptive crosssectional study in Santa Clara municipality, Villa Clara, in 2010. The sample consisted of 181 pregnant women who had at least two risk factors, a survey including risk factors was carried out by them, depending on the individual risk; follow up and early diagnosis of serious and emerging preeclampsia strategies were conceived. Results: Patients at both extreme of age represented 58,01 % of the total, with 105 women, prevailing advanced maternal age subgroup: 69 (38,12 %). Cardiovascular risk was result of the low calcium intake, the risk of thromboembolic disease, sustained stress, and waist-hip ratio greater than 0,85. The main risks of metabolic syndrome were waist circumference greater than 88 cm and high levels of triglycerides. Conclusions: It can be stratified by using the risk approach, depending on the characteristics of the pregnant women who were studied; also it facilitates identifying cardiovascular and metabolic syndrome risks in pregnant women with preeclampsia risk.


REFERENCES

  1. Witlin AG, Sibai Baha. Hypertension in pregnancy: current concepts of pre-eclampsia. An Rev Med. 2007;48:125-7.

  2. Dekker GM. Etiology and pathogenesis of pre-eclampsia: current concepts. Am J Obst Gynecol. 2008;5(179):1359-75.

  3. Ruiz Villaverde G, Abalos Medina GM, Villaverde Gutiérrez C. Estimación de riesgo cardiovascular en pacientes con síndrome metabólico (SM). Medwave [Internet]. 2009 mar. [citado 2 feb. 2011];9(3):[aprox. 6 p.]. Disponible en: http://www.mednet.cl/link.cgi/Medwave/Revisiones/RevisionClinica/3839

  4. Anuario Estadístico de Salud 2011. Edición Especial [Internet]. La Habana: Ministerio de Salud Pública. Dirección Nacional de Registros Médicos y Estadística de Salud. 2012 abr. [citado 5 mayo 2012]. Disponible en: http://files.sld.cu/dne/files/2012/04/anuario-2011-e.pdf

  5. Sack DB, Path RC. Carbohydrate. En: Burtis C, Ashwood E, Bruns D. Fundamentals of Clinical Chemistry. 6th ed. Philadelphia: Saunders Elsevier; 2008. p. 382-4.

  6. Ruiz Moré AA, León Guada Y, Burgos Ballate D, Sarduy Santana J, Linares Rodríguez O, Hernández Durán B. Alteraciones del metabolismo lipídico en adultos mayores de 60 años con enfermedades crónicas no transmisibles. Rev Mex Patol Clín [Internet]. 2009 [citado 14 jun. 2011];56(1):[aprox. 9 p.]. Disponible en: http://www.medigraphic.com/pdfs/patol/pt- 2009/pt091f.pdf

  7. Ramírez Arriola MC, Mendoza Romo MP, González Rubio MV, López Esqueda FJ, Mendoza Romo MA, Velasco Chávez JF. Correlación de los componentes del síndrome metabólico en mujeres mexicanas mayores de 60 años. Ginecol Obstet Mex [Internet]. 2011 [citado 18 dic. 2011];79(1):[aprox. 6 p.]. Disponible en: http://www.medigraphic.com/pdfs/ginobsmex/gom- 2011/gom111d.pdf

  8. Rigo JC, Vieira JL, Rigo Dalacorte R, Reichert CL. Prevalencia de síndrome metabólico en adultos mayores. Comparación entre tres métodos diagnósticos. Arq Bras Cardiol [Internet]. 2009 [citado 27 mar. 2011];93(2):[aprox. 7 p.]. Disponible en: http://www.arquivosonline.com.br/espanol/2009/9302/PDF/e9302004.pdf

  9. Balesterana Sánchez JM, Pereda Padilla S. El calcio en los estados hipertensivos del embarazo. Rev Cubana Obstet Ginecol. 2000;26(1).

  10. Sánchez Padrón A, Sánchez Valdivia A, Bello Vega M, Somoza ME. Enfermedad hipertensiva en el embarazo. Rev Cubana Med Intens Emerg. 2004;3(1):62-96.

  11. Gómez Sosa E. Trastornos hipertensivos durante el embarazo. Rev Cubana Obstet Ginecol. 2000;26(2).

  12. World Health Organization. The World Health Report 2010 [Internet]. 2010 [citado 18 ene. 2011]. Disponible en: http://apps.who.int/infobase/?id=1

  13. Garber AJ, Handelsman Y, Einhorn D, Berman DA, Bloomgarden ZT, Fonseca V, et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia- When do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologist. Endocr Pract. 2008;14(7):933-46.

  14. Castillo Arocha I, Armas Rojas NB, Dueñas Herrera A, González Greck OR, Arocha Mariño C, Castillo Guzmán A. Riesgo cardiovascular según tablas de la OMS, el estudio Framingham y la razón apolipoproteína B/apolipoproteína A1. Rev Cubana Invest Bioméd [Internet]. 2010 [citado 12 jun. 2011];29(4):[aprox. 10 p.]. Disponible en: http://scielo.sld.cu/pdf/ibi/v29n4/ibi08410.pdf

  15. Achaval Giraud A. Hiperlipidemias y ateroesclerosis. Diagnóstico y tratamiento. Rev Fed Arg Cardiol [Internet]. 2009 ene.-mar. [citado 12 jun. 2011];38(1):[aprox. 10 p.]. Disponible en: http://moodle.fac.org.ar/1/revista/09v38n1/art_revis/revis01/achaval.pdf

  16. Stoney RM. Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with Type 2 diabetes mellitus. Diabet Med. 2001 Jun.;18:476-82.

  17. Huamán Saavedra JJ, Castillo Minaya KY, Corrales Portales DA, Reyes Beltrán ME. Categorías de riesgo coronario y logro de la meta de LDL colesterol según edad y género en la población adulta de Trujillo, La Libertad, Perú 2007. Acta Med Per [Internet]. 2008 [citado 16 oct. 2011];25(2):[aprox. 6 p.]. Disponible en: http://www.scielo.org.pe/pdf/amp/v25n2/a04v25n2.pdf




2020     |     www.medigraphic.com